Immunization Practices in Children with Nephrotic Syndrome


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-007634
    Sponsor Protocol Number: 15-007634

About this study

The primary goal of this study is to survey pediatric nephrologists to investigate their immunization practices in children with nephrotic syndrome (NS) and to assess the parental knowledge of immunization recommendations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:


  1. Pediatric patients (<18 years old) with Nephrotic Syndrome diagnosed from 2005 to present.
  2. Have seen their pediatric nephrologist at least once in order to be given the survey for completion.

Pediatric Nephrologists

  1. Pediatric Nephrologists at the respective Midwest Pediatric Nephrology Consortium (MWPNC) participating site.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Cheryl Tran, M.D.

Contact us for the latest status

Contact information:

Cheryl Tran M.D.